The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

LRIG2  -  leucine-rich repeats and immunoglobulin...

Homo sapiens

Synonyms: KIAA0806, LIG-2, LIG2, Leucine-rich repeats and immunoglobulin-like domains protein 2, UFS2
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of LRIG2

  • A double blind clinical study demonstrated an approximately 2.0- and 1.6-fold increase in average percentage improvement in healing of the lesions in patients suffering from HSV-1 and HSV-2 diseases, respectively, when treated with LIG-2 compared with PIG-2 [1].
  • A comparative double blind clinical pilot study of optimized LIG-2 gel was carried out for eight weeks and compared with PIG-2 on 20 Herpes simplex patients (10 patients each for HSV-1 and HSV-2, divided into two groups each of 5 patients) [1].
 

High impact information on LRIG2

 

Biological context of LRIG2

 

Associations of LRIG2 with chemical compounds

  • The LRIG2 protein was predicted to have the same domain organization as LRIG1 with a signal peptide, an extracellular part containing15 leucine-rich repeats and three immunoglobulin-like domains, a transmembrane domain, and a cytoplasmic tail [2].
 

Other interactions of LRIG2

  • Approximately 2.2- and 2.5-fold increase in skin drug retention in LIG-1 and LIG-2, respectively, was determined [1].
 

Analytical, diagnostic and therapeutic context of LRIG2

References

  1. Topical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implications. Seth, A.K., Misra, A., Umrigar, D. Pharmaceutical development and technology. (2004) [Pubmed]
  2. Characterization and tissue-specific expression of human LRIG2. Holmlund, C., Nilsson, J., Guo, D., Starefeldt, A., Golovleva, I., Henriksson, R., Hedman, H. Gene (2004) [Pubmed]
  3. Evaluation of lig-based conventional and real time PCR for the detection of pathogenic leptospires. Palaniappan, R.U., Chang, Y.F., Chang, C.F., Pan, M.J., Yang, C.W., Harpending, P., McDonough, S.P., Dubovi, E., Divers, T., Qu, J., Roe, B. Mol. Cell. Probes (2005) [Pubmed]
 
WikiGenes - Universities